Concepedia

Author

Keiichi Aritomo

Mitsubishi Tanabe Pharma Corporation

Also Known As

K. ARITOMO, Keiichi Aritomo

10

Publications

139

Citations

6

H-Index

28

Concepts

All Affiliations

Mitsubishi Tanabe Pharma CorporationMitsubishi Chemical (Japan)
KA

About

Keiichi Aritomo is an author at Mitsubishi Tanabe Pharma Corporation specializing in medicine, drug discovery, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

111

2

Natural Sciences

4

4

82

3

Biochemistry

4

4

90

4

Engineering

1

1

18

5

Social Sciences

1

1

19

Keiichi Aritomo

×

6

Publications

129

Citations

6

H-Index

YearCitations

2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors

Kenji Fukunaga, Fumiaki Uehara, Keiichi Aritomo,

Bioorganic & Medicinal Chemistry Letters

2013

32

6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitors

Fumiaki Uehara, Aya Shoda, Keiichi Aritomo,

Bioorganic & Medicinal Chemistry Letters

2013

28

Structural Characterization of Cyclic ADP-Ribose by NMR Spectroscopy

Takeshi Wada, Kiyoshi Inageda, Keiichi Aritomo,

Nucleosides and Nucleotides

1995

21

Synthesis and Biological Evaluation of Cyclopentaquinoline Derivatives as Nonsteroidal Glucocorticoid Receptor Antagonists

Masahiro Eda, Tomoko Kuroda, Satoshi Kaneko,

Journal of Medicinal Chemistry

2015

19

Alkylation of 6-N-acylated adenosine derivatives by the use of phase transfer catalysis

Keiichi Aritomo, Takeshi Wada, Mitsuo Sekine

Journal of the Chemical Society Perkin Transactions 1

1995

18

Discovery of novel 2-(3-phenylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors

Yoshihiro Usui, Fumiaki Uehara, Shinsuke Hiki,

Bioorganic & Medicinal Chemistry Letters

2017

11

Page 1